RVL Pharmaceuticals
Jordan Mathews is an experienced sales professional with a focus on the pharmaceutical industry. Currently serving as an Eye Care Territory Manager at RVL Pharmaceuticals, Inc. since November 2018, Jordan previously held the position of Dermatology Sales Specialist at Mayne Pharma from October 2017 to October 2018. Prior experience includes working as a Territory Business Manager at Crown Laboratories, Inc. and as a Dermatology Sales Specialist at Mylan, where Jordan achieved recognition as a top volume performer and was a member of the Presidents Club in 2015. Jordan holds a Bachelor's Degree in Kinesiology and Exercise Science from Wesley College, Delaware, completed in 2013.
RVL Pharmaceuticals
RVL Pharmaceuticals plc is a specialty pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. The Company is currently commercializing UPNEEQ® (oxymetazoline hydrocholoride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. UPNEEQ is the first non-surgical treatment option approved by the FDA for acquired blepharoptosis.